BR102021009475B1 - Métodos para análise quantitativa e/ou qualitativa de marcadores peptídicos de sarscov-2 e usos de peptídeos de sars-cov-2 para fins de diagnóstico - Google Patents

Métodos para análise quantitativa e/ou qualitativa de marcadores peptídicos de sarscov-2 e usos de peptídeos de sars-cov-2 para fins de diagnóstico Download PDF

Info

Publication number
BR102021009475B1
BR102021009475B1 BR102021009475-3A BR102021009475A BR102021009475B1 BR 102021009475 B1 BR102021009475 B1 BR 102021009475B1 BR 102021009475 A BR102021009475 A BR 102021009475A BR 102021009475 B1 BR102021009475 B1 BR 102021009475B1
Authority
BR
Brazil
Prior art keywords
peptide
peptides
cov
sars
sample
Prior art date
Application number
BR102021009475-3A
Other languages
English (en)
Portuguese (pt)
Other versions
BR102021009475A2 (US06312121-20011106-C00033.png
Inventor
Karina Helena Morais Cardozo
Guilherme Gonçalves Okai
Adriana Lebkuchen
Rodrigo Andrade Schuch
Luciana Godoy Viana
Aline Nogueira Olive
Carolina Dos Santos Lazari
Ana Maria Fraga
Celso Francisco Hernandes Granato
Maria Carolina Tostes Pintão
Valdemir Melechco Carvalho
Original Assignee
Fleury S/A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fleury S/A filed Critical Fleury S/A
Priority to BR102021009475-3A priority Critical patent/BR102021009475B1/pt
Publication of BR102021009475A2 publication Critical patent/BR102021009475A2/pt
Publication of BR102021009475B1 publication Critical patent/BR102021009475B1/pt

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry

Landscapes

  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
BR102021009475-3A 2021-05-14 2021-05-14 Métodos para análise quantitativa e/ou qualitativa de marcadores peptídicos de sarscov-2 e usos de peptídeos de sars-cov-2 para fins de diagnóstico BR102021009475B1 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR102021009475-3A BR102021009475B1 (pt) 2021-05-14 2021-05-14 Métodos para análise quantitativa e/ou qualitativa de marcadores peptídicos de sarscov-2 e usos de peptídeos de sars-cov-2 para fins de diagnóstico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102021009475-3A BR102021009475B1 (pt) 2021-05-14 2021-05-14 Métodos para análise quantitativa e/ou qualitativa de marcadores peptídicos de sarscov-2 e usos de peptídeos de sars-cov-2 para fins de diagnóstico

Publications (2)

Publication Number Publication Date
BR102021009475A2 BR102021009475A2 (US06312121-20011106-C00033.png) 2021-10-26
BR102021009475B1 true BR102021009475B1 (pt) 2022-09-20

Family

ID=83853055

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102021009475-3A BR102021009475B1 (pt) 2021-05-14 2021-05-14 Métodos para análise quantitativa e/ou qualitativa de marcadores peptídicos de sarscov-2 e usos de peptídeos de sars-cov-2 para fins de diagnóstico

Country Status (1)

Country Link
BR (1) BR102021009475B1 (US06312121-20011106-C00033.png)

Also Published As

Publication number Publication date
BR102021009475A2 (US06312121-20011106-C00033.png) 2021-10-26

Similar Documents

Publication Publication Date Title
Cardozo et al. Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts
Messner et al. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection
Singh et al. A rapid and sensitive method to detect SARS-CoV-2 virus using targeted-mass spectrometry
Williams et al. The integration of SPR biosensors with mass spectrometry: possible applications for proteome analysis
Woo et al. Three-dimensional feature matching improves coverage for single-cell proteomics based on ion mobility filtering
Qin et al. SRM targeted proteomics in search for biomarkers of HCV‐induced progression of fibrosis to cirrhosis in HALT‐C patients
Griffin et al. Mass spectrometry analytical responses to the SARS-CoV2 coronavirus in review
Ceglarek et al. Quantification of seven apolipoproteins in human plasma by proteotypic peptides using fast LC‐MS/MS
Van Puyvelde et al. Cov-MS: a community-based template assay for mass-spectrometry-based protein detection in SARS-CoV-2 patients
Cardozo et al. Fast and low-cost detection of SARS-CoV-2 peptides by tandem mass spectrometry in clinical samples
Bezstarosti et al. Targeted proteomics for the detection of SARS-CoV-2 proteins
CA2433281C (en) Rapid and quantitative proteome analysis and related methods
JP2022123057A (ja) Ａｄａｍｔｓ１３酵素活性を決定するための方法およびシステム
Kontostathi et al. Development and validation of multiple reaction monitoring (MRM) assays for clinical applications
Renuse et al. Development of mass spectrometry-based targeted assay for direct detection of novel SARS-CoV-2 coronavirus from clinical specimens
Rice et al. Optimizing data‐independent acquisition (DIA) spectral library workflows for plasma proteomics studies
Guo et al. A qualitative and quantitative evaluation of the peptide characteristics of microwave‐and ultrasound‐assisted digestion in discovery and targeted proteomic analyses
RU2748540C1 (ru) Способ детектирования вируса SARS-CoV-2 методом масс-спектрометрии
Feng et al. Selected reaction monitoring to measure proteins of interest in complex samples: a practical guide
BR102021009475B1 (pt) Métodos para análise quantitativa e/ou qualitativa de marcadores peptídicos de sarscov-2 e usos de peptídeos de sars-cov-2 para fins de diagnóstico
Kingon et al. Multi-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer model
Matthiesen et al. Analysis of mass spectrometry data in proteomics
Carroll et al. Quantification of proteins and their modifications using QconCAT technology
CN113125757A (zh) 一种用于母猪早期妊娠诊断的蛋白生物标志物及其用于母猪早期妊娠诊断方法
WO2013166343A2 (en) Mrm-ms signature assay

Legal Events

Date Code Title Description
B03B Publication of an application: publication anticipated [chapter 3.2 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/05/2021, OBSERVADAS AS CONDICOES LEGAIS